Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01999855
Other study ID # 5517
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date December 2013
Est. completion date December 2017

Study information

Verified date September 2017
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For many years, it is known that asthmatics have more often dysphonia. However, no study has so far analyzed the reality of dysphonia in asthmatic by making phoniatric tests.

The etiology of dysphonia in asthmatic remains controversial. Indeed, for a long time, inhaled corticosteroids have been considered as responsible for organic abnormalities of the vocal cords. We hypothesized that women with asthma have more often dysphonia, and that dysphonia is rather functional origin.


Recruitment information / eligibility

Status Terminated
Enrollment 137
Est. completion date December 2017
Est. primary completion date September 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Women

- Aged between 18 to 65 years

- Patient who signed the informed consent.

- affiliated with a social security system.

Patients with asthma (GINA criteria)

- persistent asthma with inhaled corticosteroids.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Phoniatric tests


Locations

Country Name City State
France Service de pneumologie, d'allergologie et de pathologie de l'environnement Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evidence of dysphonia. The patient will be considered as having a dysphonia if at least one of the tests (Voice Handicap Index, Rank Rough Breathy Asthenic Strained GRBAS, Quotien Phonatoire QP and Fundamental laryngeal F0) is abnormal Four week